Chemical Entities of Biological Interest
8596 terms(s) returned
| Term Type: | Record: 151 to 200 of 8596 Records | Page: 4 of 172, First Previous Next Last | Show Records Per Page |
- (12R)-hydroxy-10,11-dihydroleukotriene E4(1-)
- (12RS)-(8E,10E)-12-hydroxy-7-oxo-8,10-octadecadienoic acid
- (12S)-4,5-Dimethoxy-12-methyl-13-oxa-10-azatetracyclo[8.7.0.02,7.011,15]heptadeca-2,4,6,11(15)-tetraen-14-one
- (12S)-hydroperoxy-(14R,15S)-epoxy-(5Z,8Z,10E)-icosatrienoate
- (12S)-hydroperoxy-(14R,15S)-epoxy-(5Z,8Z,10E)-icosatrienoic acid
- (12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoate
- (12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoic acid
- (12Z)-10-hydroxyoctadec-12-enoic acid
- (12Z,15Z,18Z,21Z,24Z)-triacontapentaenoate
- (12Z,15Z,18Z,21Z,24Z)-triacontapentaenoic acid
- (12Z,15Z,18Z,21Z,24Z)-triacontapentaenoyl-CoA
- (12Z,15Z,18Z,21Z,24Z)-triacontapentaenoyl-CoA(4-)
- (12Z,15Z,18Z,21Z,24Z,27Z)-triacontahexaenoate
- (132S, 17S, 18S)-132-hydroxy-20-chloro-ethylpheophorbide a
- (13E)-10-hydroxy-7,7,13,17,18-pentamethyl-20-(2-methylpropyl)-2,6,8-trioxa-21-azatetracyclo[13.7.0.01,19.05,9]docosa-13,16-diene-3,22-dione
- (13E)-labda-7,13-dien-15-ol
- (13R)-13-dihydrocarminomycin
- (13R)-13-hydroxymyristic acid
- (13R)-HPODE
- (13R)-S-cysteinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid
- (13R)-S-cysteinylglycinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid
- (13R)-S-glutathionyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid
- (13R)-edaxadiene
- (13R)-epi-8,13-epoxylabd-14-ene
- (13R)-manoyl oxide
- (13R,14E)-14-Ethylidene-12-methylidene-1,10-diazatetracyclo[11.2.2.03,11.04,9]heptadeca-3(11),4,6,8-tetraene
- (13R,14R)-7-Labdene-13,14,15-triol
- (13R,14S)-dihydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid
- (13S)-12,13-epoxyoctadeca-9,11-dienoic acid
- (13S)-13-dihydrodaunorubicin
- (13S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one
- (13S)-edaxadiene
- (13S)-hydroxy-(14S,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoic acid
- (13S,14R)-1,13-dihydroxy-N-methylcanadine
- (13S,14R)-1,8-dihydroxy-13-O-acetyl-N-methylcanadine
- (13S,14R)-1-hydroxy-13-O-acetyl-N-methylcanadine
- (13S,14S)-epoxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoate
- (13S,14S)-epoxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid
- (13S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol
- (13S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- (13S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
- (13S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
- (13S,17R)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
- (13S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
- (13Z)-3-Hydroxyicos-13-enoylcarnitine
- (13Z)-3-hydroxy-2-{[(2S)-2-hydroxytetradecanoyl]amino}icos-13-en-1-yl alpha-D-Man-(1->2)-alpha-D-Gal-(1->6)-alpha-D-GlcN-(1->4)-alpha-D-GlcA
- (13Z)-docosen-1-ol
- (13Z)-octadecen-1-ol
- (13Z)-octadecenoate
- (13Z)-octadecenoic acid
